Clinical trials
Diabetic Kidney Disease clinical trials
Below are recruiting diabetic kidney disease clinical trials, each written for real people, not researchers. We’re tracking 323 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06698614Recruiting
Magnetic resonance imaging to study kidney disease
This study uses a special MRI scan to look at the kidneys in people with different kinds of kidney disease, including acute kidney injury, chronic kidney disease, vasculitis, and after a kidney transplant. The goal is to better understand these conditions.
EdinburghAges 18 years+ - NCT04297592Enrolling by invitationPhase 4
Antibiotics to prevent infection after hip or knee replacement
This trial studies whether giving antibiotics before and/or after surgery can lower the chance of a serious joint infection after elective hip or knee replacement. It’s aimed at people at higher risk for infection.
Iowa City, IowaAges 18–99 - NCT06717698RecruitingPhase 2
Testing a new medicine for kidney damage in chronic kidney disease
This study tests different doses of an investigational medicine (NNC0519-0130) to see if it can reduce kidney damage in people with chronic kidney disease. It may be an option for you if you have kidney impairment and either have or don't have type 2 diabetes.
San Dimas, CaliforniaAges 18 years+ - NCT06752577Recruiting
Stem cell treatment for chronic kidney disease safety study
This study tests whether a single infusion of stem cells from bone marrow is safe for people with chronic kidney disease (CKD). It aims to see if this treatment can help slow kidney function loss.
Jacksonville, FloridaAges 18 years+ - NCT06794593RecruitingPhase 2
Camostat for kidney protection in chronic kidney disease
This study tests if a drug called camostat can help protect the kidneys in people with chronic kidney disease. It also includes a group of healthy volunteers for comparison.
OdenseAges 18 years+ - NCT06821919Recruiting
Diabetes and immune drugs in kidney disease study
This study looks at how diabetes treatments and immune-suppressing drugs affect a process called NETosis, which involves immune cells forming traps. It may help find better ways to treat kidney disease in people with diabetes or immune-related kidney problems.
NahariyaAges 18 years+ - NCT06838416Recruiting
Study on finerenone for kidney health in type 2 diabetes
This trial tests if a medicine called finerenone can protect kidney function in people with type 2 diabetes and early-to-moderate chronic kidney disease. It may be an option if you are already on blood pressure medication and have some protein in your urine.
Suzhou, JiangsuAges 18 years+ - NCT06846034Recruiting
How low oxygen affects kidney blood flow
This study tests how low oxygen levels affect blood flow in the kidneys. It includes healthy people, people with type 2 diabetes, and those with diabetes plus kidney disease to see if their kidneys respond differently.
PoitiersAges 18–75 - NCT06897605RecruitingPhase 2
Dapagliflozin for anemia in kidney disease
This trial tests whether a medication called dapagliflozin can help improve anemia in people with chronic kidney disease. If you have moderate to severe kidney disease and low red blood cell counts despite taking standard anemia treatment, this study may explore a new option.
Al MansurahAges 18 years+ - NCT06907147Recruiting
Renal denervation for uncontrolled high blood pressure
This trial tests a procedure called renal denervation to lower blood pressure in people whose medication isn't enough. It uses a special catheter to calm nerves near the kidneys that may be overactive.
Stanford, CaliforniaAges 18–80 - NCT06925217Recruiting
Closed-loop insulin for type 2 diabetes and kidney disease
This study tests whether a special type of insulin delivery system (closed-loop) can help people with type 2 diabetes and chronic kidney disease. You'll wear a continuous glucose monitor and insulin pump, and researchers will track how your kidneys respond over time.
Lausanne, Canton of VaudAges 18 years+ - NCT06966258Recruiting
Heart health program for Black women in Birmingham
This trial tests a program called Inspire HER, which aims to improve heart and emotional health for Black women with early-stage cardiovascular-kidney-metabolic syndrome. You may qualify if you have this condition and live in the Birmingham area.
Birmingham, AlabamaAges 30–79 - NCT06982079RecruitingPhase 3
SGLT2 inhibitors for advanced kidney disease
This trial tests whether SGLT2 inhibitor drugs can protect kidney function in people with advanced chronic kidney disease who are not yet on dialysis. It may help slow further kidney decline.
CairoAges 18 years+ - NCT07017270RecruitingPhase 4
GLP-1 drugs for people with diabetes on dialysis
This study tests if a type 2 diabetes medication called a GLP-1 receptor agonist (like Ozempic) is safe and effective for people on dialysis. It may help manage blood sugar and improve health outcomes for those with kidney failure.
Toronto, OntarioAges 18 years+ - NCT07022418RecruitingPhase 2
Formoterol for diabetic kidney disease
This trial tests if a drug called formoterol (usually used for asthma) can help protect the kidneys in people with type 2 diabetes and early-to-moderate kidney disease. It may offer a new way to slow kidney damage.
Charleston, South CarolinaAges 18–75 - NCT07026539RecruitingPhase 4
Finerenone for heart and kidney health in type 2 diabetes
This trial tests whether adding finerenone to your current diabetes medications can better protect your heart and kidneys. It is for people with type 2 diabetes who already take an SGLT2 inhibitor and an ACE inhibitor or ARB.
Aarhus NAges 18 years+ - NCT07043166Recruiting
Heart, kidney, and metabolic health study in Shanghai
This study looks at the link between heart, kidney, and metabolic health in adults living in Shanghai. It follows people who were part of an earlier health study to see how their health changes over time.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07086989Recruiting
Heart health study for kids with chronic conditions
This study looks at heart disease risk in children and young adults (ages 6-25) with long-term health conditions like certain heart, kidney, or diabetes disorders. The goal is to better understand and manage heart risks early.
BudapestAges 6–25 - NCT07169422Recruiting
Pharmacist prescribing for kidney care in type 2 diabetes
This study tests whether having a pharmacist prescribe kidney-protective medications works better than usual care for people with type 2 diabetes and early kidney disease. If you don't have a family doctor, you may be able to get these medications more easily through a pharmacist.
Halifax, Nova ScotiaAges 18 years+ - NCT07180368Recruiting
Managing multiple medications in older adults
This study looks at how to better manage multiple medications in older adults with long-term health conditions. It aims to improve safety and reduce drug-related problems.
Xi'an, ShaanxiAges 65 years+ - NCT07182422RecruitingPhase 4
AST-120 for kidney protection after acute kidney injury
This trial tests if the drug AST-120 (Kremezin) can help protect your kidneys and slow down further kidney decline after a recent acute kidney injury. It is for people who had a moderate to severe kidney injury during a hospital stay and now have mild to moderate chronic kidney damage.
TaoyuanAges 18–80 - NCT07187713RecruitingPhase 4
Study of ACE Reno, Pico Cell Matrix for kidney health
This trial tests a new treatment called ACE Reno, Pico Cell Matrix to see if it can improve kidney function in people with chronic kidney disease (CKD) at various stages. It may be an option if you have early to moderate kidney issues (including after a transplant) and are already on standard therapies.
Giza, GZAges 18–80 - NCT07194733Recruiting
Food as medicine for veterans with kidney disease
This trial tests whether providing healthy food can improve the health of veterans with moderate to severe chronic kidney disease (stages 3b and 4) who are not getting enough nutritious food. If you are a VA patient in the Food Bank of the Rockies area, this study may help you manage your kidney disease.
Aurora, ColoradoAges 18 years+ - NCT07232537Recruiting
Study of finerenone in kidney disease with diabetes
This study is for people in South Korea who have chronic kidney disease and type 2 diabetes and are already taking or about to start the medicine finerenone (Kerendia). The goal is to see how well finerenone works in everyday medical care, outside of a strict research setting.
Multiple LocationsAges 18 years+
Hear when a new Diabetic Kidney Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diabetic kidney disease?
- Yes. Clin2 currently lists 323 recruiting diabetic kidney disease studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diabetic kidney disease trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diabetic kidney disease trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.